Featured Research

from universities, journals, and other organizations

'Super Glue' Seals Bypass Grafts

Date:
April 14, 2004
Source:
Baylor College Of Medicine
Summary:
Surgeons at Baylor College of Medicine in Houston are studying whether a liquid sealant, similar to common household "super glue," forms a tight seal around blood vessels used in vascular graft surgery.

HOUSTON -- Got a broken teacup, an art project, or a leaky blood vessel? “Super glue” it.

Surgeons at Baylor College of Medicine in Houston are studying whether a liquid sealant, similar to common household “super glue,” forms a tight seal around blood vessels used in vascular graft surgery.

“When you sew blood vessels together for a graft, they sometimes leak,” said Dr. Alan Lumsden, chief of the vascular surgery section of the Michael E. DeBakey Department of Surgery and principal investigator for the clinical trial. “In this trial, we will seal that leak, or basically “super glue” it together.”

Doctors currently use the glue to close skin wounds instead of using sutures, and are now studying it for vascular grafts. The sealant, manufactured by Closure Medical Corporation, is designed to provide a strong physical seal that remains in place longer than the graft takes to heal naturally. Over time, the seal will break down into smaller absorbable fragments.

Lumsden is the principal investigator of the international clinical trial, which will enroll up to 150 patients at 14 institutions in the United States and Europe. Surgeries will be performed at The Methodist Hospital and the Michael E. DeBakey Houston VA Medical Center. Candidates for the study are patients who are having femoral-popliteal bypass or AV access shunt surgery, two procedures that improve blood flow. Ideal candidates for the surgery are those who will be receiving artificial grafts, which bleed more, leading to surgical complications.

Other methods currently available to seal leaky blood vessels use biological agents to clot the blood. Since the vascular sealant is synthetic, it carries no risk of viral contamination or rejection that may occur with biological agents.

“The idea is that we can use this glue to join two blood vessels which allows blood to flow from one to the other--something we currently cannot do,” Lumsden said.

Patients in the trial will either receive the procedure using the glue, or sutures alone. Researchers will then compare the procedures to measure blood loss and the time the procedure takes to complete.

“Because we cannot create a tight, leak-proof seal between blood vessels, vascular surgeons are unable to perform laparascopic vascular surgery, a minimally invasive form of surgery,” Lumsden said. “The glue opens up all types of possibilities in terms of vascular graft surgery.”


Story Source:

The above story is based on materials provided by Baylor College Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Baylor College Of Medicine. "'Super Glue' Seals Bypass Grafts." ScienceDaily. ScienceDaily, 14 April 2004. <www.sciencedaily.com/releases/2004/04/040414003300.htm>.
Baylor College Of Medicine. (2004, April 14). 'Super Glue' Seals Bypass Grafts. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/04/040414003300.htm
Baylor College Of Medicine. "'Super Glue' Seals Bypass Grafts." ScienceDaily. www.sciencedaily.com/releases/2004/04/040414003300.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins